Over the first half of 2019, a staggering $170B has been pledged to biopharma buyout activities, an amount that exceeds the total deal spend of the last three years combined. With the increasing complexity and frequency of biopharma M&A transactions, how do you ensure that synergy targets are met or exceeded? What are some of the key success factors, and what are some of the biggest ‘real-world’ pitfalls and watch-outs to address? In this panel we will be exploring these topics with highly experienced “roll-up-the sleeves” executives who have succeeded in M&A where others have failed. Please send your questions in advance, as this engaging talk promises to offer tangible lessons learned and takeaways. In this panel we will be exploring these topics with highly experienced “roll-up-the sleeves” executives who have succeeded in M&A where others have failed. Please send your questions in advance, as this engaging talk promises to offer tangible lessons learned and takeaways.
LEADING FIRMS SHARE THEIR KNOWLEDGE ON EXPERT WEBCAST:
About the Author
Expert Webcast is a sophisticated digital source of expertise for the professional and the business communities locally, nationally and cross-border.
Producing the industry’s leading webcast panels covering corporate, M&A, restructuring and finance topics, Expert Webcast addresses timely and relevant issues faced by business owners, C-level executives, corporate advisers and institutional investors.
Licensing & Reprints
Expert Webcast does not authorize or allow the use of our content, including, but not limited to, presentation materials, logos, text, photographs, graphics, data, webcasts, and audio and video recordings, other than pursuant to a purchased license... >>Click for more
Disclaimer: Expert Webcast does not provide legal services or accepts or assumes responsibility, or has any liability, to any person in respect of any Expert Webcast presentations or other communications... >>Click for more